BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20958072)

  • 1. Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.
    Li C; Penet MF; Wildes F; Takagi T; Chen Z; Winnard PT; Artemov D; Bhujwalla ZM
    ACS Nano; 2010 Nov; 4(11):6707-16. PubMed ID: 20958072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.
    Chen Z; Penet MF; Krishnamachary B; Banerjee SR; Pomper MG; Bhujwalla ZM
    Biomaterials; 2016 Feb; 80():57-67. PubMed ID: 26706476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided enzyme/prodrug cancer therapy.
    Li C; Penet MF; Winnard P; Artemov D; Bhujwalla ZM
    Clin Cancer Res; 2008 Jan; 14(2):515-22. PubMed ID: 18223227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Progression of Lung Metastases Following Delivery of a Prodrug-activating Enzyme.
    Dore-Savard L; Chen Z; Winnard PT; Krishnamachary B; Raman V; Black ME; Bhujwalla ZM
    Anticancer Res; 2017 May; 37(5):2195-2200. PubMed ID: 28476782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMA-targeted theranostic nanoplex for prostate cancer therapy.
    Chen Z; Penet MF; Nimmagadda S; Li C; Banerjee SR; Winnard PT; Artemov D; Glunde K; Pomper MG; Bhujwalla ZM
    ACS Nano; 2012 Sep; 6(9):7752-7762. PubMed ID: 22866897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
    Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
    Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging.
    Aboagye EO; Artemov D; Senter PD; Bhujwalla ZM
    Cancer Res; 1998 Sep; 58(18):4075-8. PubMed ID: 9751613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
    Chung T; Na J; Kim YI; Chang DY; Kim YI; Kim H; Moon HE; Kang KW; Lee DS; Chung JK; Kim SS; Suh-Kim H; Paek SH; Youn H
    Theranostics; 2016; 6(10):1477-90. PubMed ID: 27446484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.
    Park JI; Cao L; Platt VM; Huang Z; Stull RA; Dy EE; Sperinde JJ; Yokoyama JS; Szoka FC
    Mol Pharm; 2009; 6(3):801-12. PubMed ID: 19265397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
    BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme Prodrug Therapy with Photo-Cross-Linkable Anti-EGFR Affibodies Conjugated to Upconverting Nanoparticles.
    Roy S; Curry SD; Corbella Bagot C; Mueller EN; Mansouri AM; Park W; Cha JN; Goodwin AP
    ACS Nano; 2022 Oct; 16(10):15873-15883. PubMed ID: 36129781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
    Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
    Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal image-guided enzyme/prodrug cancer therapy.
    Li C; Winnard PT; Takagi T; Artemov D; Bhujwalla ZM
    J Am Chem Soc; 2006 Nov; 128(47):15072-3. PubMed ID: 17117842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
    Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
    Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference.
    Mahan SD; Ireton GC; Stoddard BL; Black ME
    Biochemistry; 2004 Jul; 43(28):8957-64. PubMed ID: 15248753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of a novel chitosan based E. coli cytosine deaminase nanocomposite for potential application in prodrug enzyme therapy.
    Yata VK; Ghosh SS
    Biotechnol Lett; 2011 Jan; 33(1):153-7. PubMed ID: 20960222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.
    Nakamura H; Mullen JT; Chandrasekhar S; Pawlik TM; Yoon SS; Tanabe KK
    Cancer Res; 2001 Jul; 61(14):5447-52. PubMed ID: 11454690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts.
    Kievit E; Nyati MK; Ng E; Stegman LD; Parsels J; Ross BD; Rehemtulla A; Lawrence TS
    Cancer Res; 2000 Dec; 60(23):6649-55. PubMed ID: 11118048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
    Van Rite BD; Harrison RG
    Cancer Lett; 2011 Aug; 307(1):53-61. PubMed ID: 21546157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.